Gene · 4921
NIH grants1,545
NIH grants whose papers are about the gene, through NIH's grant-paper links.
761 to 780 of 1,545
Download this page as JSON| Grant | Title | DDR2 papers | Newest fiscal year |
|---|---|---|---|
| P30DK072488 | Mid-Atlantic Nutrition Obesity Research Center | 1 | 2019 |
| P50AG005138 | Alzheimer's Disease Research Center | 1 | 2019 |
| R00CA188093 | Mesenchymal Stromal Cells and Stromal Fibroblasts in Radiotherapy Resistance | 1 | 2019 |
| R00CA197816 | The SMYD3-ERK5 signaling module in pancreatic cancer | 1 | 2019 |
| R01AI116585 | TRIM9-mediated anti-viral immune pathway | 1 | 2019 |
| R01AR069588 | Engineering Microenvironments for the Nucleus Pulposus Cell | 1 | 2019 |
| R01CA142928 | Targeting the Kinome in Neurofibromatosis type 1 | 1 | 2019 |
| R01CA177669 | Dynamical Models of Cetuximab Resistance in HNSCC Based on Serial Genomics Data | 1 | 2019 |
| R01CA179120 | miRNAs:Safe and effective therapeutic adjuvants for treating drug resistant TNBC | 1 | 2019 |
| R01CA190628 | Overcoming Resistance to Anti-EGFR Therapy by Drug Repurposing | 1 | 2019 |
| R01CA190844 | Hepatic Stellate Cells and Liver Cancer | 1 | 2019 |
| R01CA195549 | Novel target for therapy refractory lung tumors | 1 | 2019 |
| R01CA195670 | The Tumor Suppressor Role of SMARCA4 in SCCOHT | 1 | 2019 |
| R01CA197178 | Selective RET Kinase and Its Mutant Inhibitors for the Treatment of Medullary Thyroid Cancer | 1 | 2019 |
| R01DE016513 | Molecular Regulation of Human Dental Stem Cell Properties | 1 | 2019 |
| R01DK108947 | Role of ADAM17 substrates in Progressive Kidney Disease | 1 | 2019 |
| R01GM045302 | NMR and biophysical studies of collagen-protein interactions and implications in biological function and disease | 1 | 2019 |
| R01GM084947 | Drosophila Transgenic RNAi Resource Project | 1 | 2019 |
| R01GM109964 | Dynamics of Non-equalibrium Cell State Transitions in Cell Populations | 1 | 2019 |
| R01GM111682 | PARylation in genotoxic stress-induced NF-kB activation | 1 | 2019 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/grants?page=39